blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3115054

EP3115054 - ANTIBACTERIAL PHAGE, PHAGE PEPTIDES AND METHODS OF USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.09.2020
Database last updated on 03.10.2024
FormerThe patent has been granted
Status updated on  18.10.2019
FormerGrant of patent is intended
Status updated on  11.06.2019
FormerExamination is in progress
Status updated on  09.03.2018
FormerRequest for examination was made
Status updated on  14.07.2017
FormerThe application has been published
Status updated on  09.12.2016
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Technophage, Investigação E Desenvolvimento Em Biotecnologia, SA
Avenida Professor Egas Moniz Edificio Egas Moniz Piso 2 Sala A8
1649-028 Lisboa / PT
For all designated states
Tecnifar-Indústria Técnica Farmacêutica, S.A.
Rua Tierno Galva Torre 3 12 Piso
1099-036 Lisboa / PT
[2017/02]
Inventor(s)01 / da Costa Garcia, Miguel Ângelo
Av. de Pádua, n.º 10, 4º B
1800-297 Lisboa / PT
02 / Sousa de São José, Carlos Jorge
Rua Alferes Barrilaro Ruas, N.º 9, 2º Dt.º/7
1800-007 Lisboa / PT
03 / Rodrigues Leandro, Clara Isabel
Praceta Eugénio Salvador, Lt. 10, R/c C
2775-089 Lisboa / PT
04 / Rodrigues Pardal Dias Antunes Marçal da Silva, @Filipa Maria
Rua do Vale, N.º1, 4º Dt.º, Belas Clube de Campo
2605-193 Belas / PT
05 / Grancho Lourenço, Sara Ferreira Llorente
Rua de Fanares, 15, 1.º Dt.º
2725-307 Mem Martins / PT
 [2017/02]
Representative(s)Ferreira, Maria Silvina, et al
Clarke, Modet & Co
Av. Casal Ribeiro, N°50-3° andar
1000-93 Lisboa / PT
[2019/47]
Former [2017/02]Ferreira, Maria Silvina, et al
Clarke, Modet & Co.
Rua Castilho, 50-9° Andar
1269-163 Lisboa / PT
Application number, filing date16172292.105.02.2010
[2017/02]
Priority number, dateUS20090150585P06.02.2009         Original published format: US 150585 P
US20090218345P18.06.2009         Original published format: US 218345 P
[2017/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3115054
Date:11.01.2017
Language:EN
[2017/02]
Type: B1 Patent specification 
No.:EP3115054
Date:20.11.2019
Language:EN
[2019/47]
Search report(s)(Supplementary) European search report - dispatched on:EP27.10.2016
ClassificationIPC:A61K35/76, C12N9/14, G01N33/569, A61K45/06, C07K14/005, C12N7/00, C12N9/64, A61K38/00
[2017/02]
CPC:
A61K35/76 (EP,RU,US); A61K9/0014 (RU,US); A61K38/00 (EP,RU,US);
A61K45/06 (EP,RU,US); A61K9/0073 (US); A61P31/00 (EP);
A61P31/04 (EP); C07K14/005 (EP,RU,US); C12N7/00 (EP,RU,US);
C12N9/6489 (EP,RU,US); G01N33/56911 (EP,RU,US); C12N2795/00032 (US);
C12N2795/10021 (EP,US); C12N2795/10022 (EP,US); C12N2795/10032 (EP,US);
C12N2795/14021 (EP,US); C12N2795/14022 (EP,US); C12N2795/14032 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2017/33]
Former [2017/02]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
TitleGerman:ANTIBAKTERIELLE PHAGE, PHAGENPEPTIDE UND VERFAHREN ZUR VERWENDUNG DAVON[2017/02]
English:ANTIBACTERIAL PHAGE, PHAGE PEPTIDES AND METHODS OF USE THEREOF[2017/02]
French:PHAGE ANTIBACTÉRIEN, PEPTIDES DE PHAGE ET MÉTHODES D'UTILISATION DE CEUX-CI[2017/02]
Examination procedure31.05.2016Date on which the examining division has become responsible
11.07.2017Amendment by applicant (claims and/or description)
11.07.2017Examination requested  [2017/33]
13.03.2018Despatch of a communication from the examining division (Time limit: M04)
29.06.2018Reply to a communication from the examining division
27.03.2019Despatch of a communication from the examining division (Time limit: M04)
23.04.2019Reply to a communication from the examining division
12.06.2019Communication of intention to grant the patent
09.10.2019Fee for grant paid
09.10.2019Fee for publishing/printing paid
09.10.2019Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP10708834.6  / EP2393502
Divisional application(s)EP19201853.9  / EP3650034
Opposition(s)21.08.2020No opposition filed within time limit [2020/44]
Fees paidRenewal fee
30.09.2016Renewal fee patent year 03
30.09.2016Renewal fee patent year 04
30.09.2016Renewal fee patent year 05
30.09.2016Renewal fee patent year 06
30.09.2016Renewal fee patent year 07
21.02.2017Renewal fee patent year 08
19.02.2018Renewal fee patent year 09
07.01.2019Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU05.02.2010
AT20.11.2019
CY20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
IT20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
MK20.11.2019
MT20.11.2019
PL20.11.2019
RO20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
TR20.11.2019
IE05.02.2020
LU05.02.2020
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
[2022/32]
Former [2022/27]HU05.02.2010
AT20.11.2019
CY20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
IT20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
MT20.11.2019
PL20.11.2019
RO20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
TR20.11.2019
IE05.02.2020
LU05.02.2020
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2021/10]AT20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
IT20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
PL20.11.2019
RO20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
IE05.02.2020
LU05.02.2020
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2021/08]AT20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
PL20.11.2019
RO20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
IE05.02.2020
LU05.02.2020
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2020/51]AT20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
PL20.11.2019
RO20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
LU05.02.2020
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2020/50]AT20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
RO20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
LU05.02.2020
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2020/48]CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
RO20.11.2019
SE20.11.2019
SK20.11.2019
SM20.11.2019
LU05.02.2020
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2020/37]CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
RO20.11.2019
SE20.11.2019
SK20.11.2019
SM20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2020/36]CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
RO20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2020/35]CZ20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
RO20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2020/26]FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2020/24]FI20.11.2019
LT20.11.2019
LV20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2020/23]FI20.11.2019
LT20.11.2019
LV20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
Former [2020/22]FI20.11.2019
LT20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
Former [2020/21]NO20.02.2020
Documents cited:Search[A]WO0069269  (EXPONENTIAL BIOTHERAPIES INC [US], et al);
 [A]WO2004052274  (PHAGE BIOPHARM LLC [US], et al);
by applicantUS5807715
 US5863560
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.